We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDNA icon
651
CareDx
CDNA
$2.6B
$347K 0.01%
+12,166
New +$265K
BSX icon
652
Boston Scientific
BSX
$62.3B
$346K 0.01%
8,105
-15,272
-65% -$829K
LXU icon
653
LSB Industries
LXU
$834M
$345K 0.01%
31,934
-17,464
-35% -$234K
REAX icon
654
Real REMAX Group Inc. Common Stock
REAX
$442M
$342K 0.01%
18,793
+3,824
+26% +$77.7K
UPS icon
655
United Parcel Service
UPS
$85.3B
$341K 0.01%
3,170
-17,106
-84% -$1.78M
ORKA
656
Oruka Therapeutics
ORKA
$6.12B
$339K 0.01%
3,557
-36,982
-91% -$2.46M
TMO icon
657
Thermo Fisher Scientific
TMO
$225B
$338K 0.01%
675
-72
-10% -$34.6K
ISTR icon
658
Investar Holding Corp
ISTR
$425M
$338K 0.01%
+11,271
New +$322K
HAL icon
659
Halliburton
HAL
$29.9B
$335K 0.01%
9,873
+1,647
+20% +$64.4K
RMD icon
660
ResMed
RMD
$31.5B
$334K 0.01%
1,712
-388
-18% -$80.4K
PLOW icon
661
Douglas Dynamics
PLOW
$929M
$333K 0.01%
+6,175
New +$285K
COF icon
662
Capital One
COF
$128B
$332K 0.01%
1,657
-359
-18% -$68.7K
TBPH icon
663
Theravance Biopharma
TBPH
$883M
$331K 0.01%
+19,478
New +$322K
A icon
664
Agilent Technologies
A
$41.4B
$325K 0.01%
2,445
-322
-12% -$39.2K
CEG icon
665
Constellation Energy
CEG
$101B
$324K 0.01%
1,304
+51
+4% +$14.4K
OTTR icon
666
Otter Tail
OTTR
$3.7B
$322K 0.01%
3,584
-5,450
-60% -$481K
NXDR
667
Nextdoor Holdings
NXDR
$878M
$322K 0.01%
+141,823
New +$265K
MCHP icon
668
Microchip Technology
MCHP
$40.3B
$322K 0.01%
3,529
-613
-15% -$54.7K
CWEN icon
669
Clearway Energy Class C
CWEN
$6.39B
$322K 0.01%
+9,413
New +$365K
SMC
670
Summit Midstream
SMC
$469M
$320K 0.01%
11,238
-2,122
-16% -$63.3K
VEON icon
671
VEON
VEON
$4.67B
$320K 0.01%
6,121
-6,529
-52% -$340K
CDNS icon
672
Cadence Design Systems
CDNS
$79.7B
$318K 0.01%
848
-12,632
-94% -$4.43M
DE icon
673
Deere & Co
DE
$182B
$317K 0.01%
500
-70
-12% -$40.5K
BTSG icon
674
BrightSpring Health Services
BTSG
$11.6B
$317K 0.01%
+4,547
New +$252K
XYL icon
675
Xylem
XYL
$25B
$310K 0.01%
+2,624
New +$303K
25 26
27
28 29

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.